- Home
- SONN vs ATCH Comparison
SONN vs ATCH Comparison
Compare SONN & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- ATCH
- Stock Information
- Founded
- SONN N/A
- ATCH 2022
- Country
- SONN United States
- ATCH United States
- Employees
- SONN N/A
- ATCH N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- SONN Health Care
- ATCH
- Exchange
- SONN Nasdaq
- ATCH Nasdaq
- Market Cap
- SONN 2.5M
- ATCH 2.3M
- IPO Year
- SONN N/A
- ATCH N/A
- Fundamental
- Price
- SONN $1.40
- ATCH $1.23
- Analyst Decision
- SONN Strong Buy
- ATCH
- Analyst Count
- SONN 2
- ATCH 0
- Target Price
- SONN $38.00
- ATCH N/A
- AVG Volume (30 Days)
- SONN 70.3K
- ATCH 10.8M
- Earning Date
- SONN 02-13-2025
- ATCH 02-19-2025
- Dividend Yield
- SONN N/A
- ATCH N/A
- EPS Growth
- SONN N/A
- ATCH N/A
- EPS
- SONN N/A
- ATCH 2.67
- Revenue
- SONN $1,000,000.00
- ATCH N/A
- Revenue This Year
- SONN N/A
- ATCH N/A
- Revenue Next Year
- SONN N/A
- ATCH N/A
- P/E Ratio
- SONN N/A
- ATCH $0.50
- Revenue Growth
- SONN 674.14
- ATCH N/A
- 52 Week Low
- SONN $1.30
- ATCH $1.05
- 52 Week High
- SONN $18.72
- ATCH $117.00
- Technical
- Relative Strength Index (RSI)
- SONN 37.25
- ATCH 34.84
- Support Level
- SONN $1.30
- ATCH $1.05
- Resistance Level
- SONN $1.52
- ATCH $1.94
- Average True Range (ATR)
- SONN 0.10
- ATCH 1.43
- MACD
- SONN -0.00
- ATCH 0.01
- Stochastic Oscillator
- SONN 33.33
- ATCH 2.39
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.